FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

McLeod Ian

2. Date of Event Requiring Statement (MM/DD/YYYY)
2/28/2018 

3. Issuer Name and Ticker or Trading Symbol

ABIOMED INC [ABMD]

(Last)        (First)        (Middle)

C/O ABIOMED, INC, 22 CHERRY HILL DR.

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
VP, Corporate Controller /

(Street)

DANVERS, MA 01923       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock, $.01 par value   7079   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)   (1) 5/13/2016   (3) 5/13/2025   Common Stock   1667   $66.25   D    
Stock Option (Right to Buy)   (2) 5/24/2017   (3) 5/24/2016   Common Stock   1334   $99.62   D    
Stock Option (Right to Buy)   (2) 5/15/2018   (3) 5/15/2027   Common Stock   3000   $134.51   D    

Explanation of Responses:
(1)  Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 3, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
(2)  Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 3, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
(3)  These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 2

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
McLeod Ian
C/O ABIOMED, INC
22 CHERRY HILL DR.
DANVERS, MA 01923


VP, Corporate Controller

Signatures
/s/ Stephen C. McEvoy (by power of attorney) 3/2/2018
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
ABIOMED (NASDAQ:ABMD)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more ABIOMED Charts.
ABIOMED (NASDAQ:ABMD)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more ABIOMED Charts.